HotOtc Featured Company: Idenix Pharmaceuticals (IDIX) Reloaded and Ready for HIV Success
Idenix Pharmaceuticals has cleared successes from its development board and is pushing forward with later stages of a phase II HIV medication. Idenix Pharmaceuticals has cleared its successes off the development board and is now ready to bring its next development products closer to market. In the past year, the company has been able to pass along its successful Tyzeka/Sebivo product to Novartis, the company’s collaboration partner, freeing capital and marketing expense. The passing along of product expenses, expected to save the company approximately $45 million, has also enabled the company to pair human resources costs and focus on development…